IL2 and neoplasm: IFN-gamma and IL-2 secretion from splenocytes (Fig. 7B-a) and tumor-infiltrating CD8+ T cells (Fig. 7B-b) from mice injected with Rv0652-OVA-DCs and then re-stimulated with OVA257–264, was higher than the IFN-gamma and IL-2 secretion from splenocytes and tumor-infiltrating CD8+ T cells from mice injected with OVA-DCs.